273 related articles for article (PubMed ID: 18937615)
1. Management of the side effects of androgen deprivation therapy in men with prostate cancer.
Flaig TW; Glodé LM
Expert Opin Pharmacother; 2008 Nov; 9(16):2829-41. PubMed ID: 18937615
[TBL] [Abstract][Full Text] [Related]
2. Adverse effects of androgen deprivation therapy and strategies to mitigate them.
Nguyen PL; Alibhai SM; Basaria S; D'Amico AV; Kantoff PW; Keating NL; Penson DF; Rosario DJ; Tombal B; Smith MR
Eur Urol; 2015 May; 67(5):825-36. PubMed ID: 25097095
[TBL] [Abstract][Full Text] [Related]
3. Metabolic changes in patients with prostate cancer during androgen deprivation therapy.
Mitsuzuka K; Arai Y
Int J Urol; 2018 Jan; 25(1):45-53. PubMed ID: 29052905
[TBL] [Abstract][Full Text] [Related]
4. Complications of androgen deprivation therapy in prostate cancer.
Schwandt A; Garcia JA
Curr Opin Urol; 2009 May; 19(3):322-6. PubMed ID: 19318949
[TBL] [Abstract][Full Text] [Related]
5. Metabolic complications of androgen deprivation therapy for prostate cancer.
Saylor PJ; Smith MR
J Urol; 2009 May; 181(5):1998-2006; discussion 2007-8. PubMed ID: 19286225
[TBL] [Abstract][Full Text] [Related]
6. Andropause syndrome in men treated for metastatic prostate cancer: a qualitative study of the impact of symptoms.
Grunfeld EA; Halliday A; Martin P; Drudge-Coates L
Cancer Nurs; 2012; 35(1):63-9. PubMed ID: 21558849
[TBL] [Abstract][Full Text] [Related]
7. Background to and management of treatment-related bone loss in prostate cancer.
Berruti A; Tucci M; Terrone C; Gorzegno G; Scarpa RM; Angeli A; Dogliotti L
Drugs Aging; 2002; 19(12):899-910. PubMed ID: 12495366
[TBL] [Abstract][Full Text] [Related]
8. [Hormone replacement therapy in prostate cancer: side effects and their management].
Bonniol R; Timsit MO
Prog Urol; 2012 Nov; 22(14):881-5. PubMed ID: 23101960
[TBL] [Abstract][Full Text] [Related]
9. Androgen deprivation therapy for prostate cancer.
Sharifi N; Gulley JL; Dahut WL
JAMA; 2005 Jul; 294(2):238-44. PubMed ID: 16014598
[TBL] [Abstract][Full Text] [Related]
10. Influence of hot flashes on quality of life in patients with prostate cancer treated with androgen deprivation therapy.
Nishiyama T; Kanazawa S; Watanabe R; Terunuma M; Takahashi K
Int J Urol; 2004 Sep; 11(9):735-41. PubMed ID: 15379937
[TBL] [Abstract][Full Text] [Related]
11. Lifestyle guidelines for managing adverse effects on bone health and body composition in men treated with androgen deprivation therapy for prostate cancer: an update.
Owen PJ; Daly RM; Livingston PM; Fraser SF
Prostate Cancer Prostatic Dis; 2017 Jun; 20(2):137-145. PubMed ID: 28117386
[TBL] [Abstract][Full Text] [Related]
12. Complications of androgen-deprivation therapy in prostate cancer: the other side of the coin.
Hoffmann P; Schulman C
BJU Int; 2009 Apr; 103(8):1020-3. PubMed ID: 19348058
[No Abstract] [Full Text] [Related]
13. Complications of Androgen Deprivation Therapy in Men With Prostate Cancer.
Patil T; Bernard B
Oncology (Williston Park); 2018 Sep; 32(9):470-4, CV3. PubMed ID: 30248169
[TBL] [Abstract][Full Text] [Related]
14. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity.
Higano CS
Urology; 2003 Feb; 61(2 Suppl 1):32-8. PubMed ID: 12667885
[TBL] [Abstract][Full Text] [Related]
15. Osteoporosis in men treated with androgen deprivation therapy for prostate cancer.
Ross RW; Small EJ
J Urol; 2002 May; 167(5):1952-6. PubMed ID: 11956415
[TBL] [Abstract][Full Text] [Related]
16. [Management of the side effects of androgenic deprivation].
Lebret T; Méjean A
Prog Urol; 2008 Nov; 18 Suppl 7():S338-42. PubMed ID: 19070813
[TBL] [Abstract][Full Text] [Related]
17. Androgen deprivation therapy: evidence-based management of side effects.
Ahmadi H; Daneshmand S
BJU Int; 2013 Apr; 111(4):543-8. PubMed ID: 23351025
[TBL] [Abstract][Full Text] [Related]
18. The role of bisphosphonates in men with prostate cancer receiving androgen deprivation therapy.
Smith MR
Oncology (Williston Park); 2004 May; 18(5 Suppl 3):21-5. PubMed ID: 15202584
[TBL] [Abstract][Full Text] [Related]
19. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy.
Israeli RS; Ryan CW; Jung LL
J Urol; 2008 Feb; 179(2):414-23. PubMed ID: 18076933
[TBL] [Abstract][Full Text] [Related]
20. Adverse effects of androgen deprivation therapy in patients with prostate cancer: focus on metabolic complications.
Tzortzis V; Samarinas M; Zachos I; Oeconomou A; Pisters LL; Bargiota A
Hormones (Athens); 2017 Apr; 16(2):115-123. PubMed ID: 28742500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
